Their findings may help improve future ways to deliver this cellular immunotherapy for metastatic ... with human chronic obstructive pulmonary disease (COPD)-associated ...

Researchers at Baylor College of Medicine and collaborating institutions have uncovered a key molecular player that is ...

Algae-based microrobots developed at UC San Diego could revolutionize lung disease treatment with targeted medication ...

During a Community Case Forum event, Antoinette R. Tan, MD, MHS, discussed the DESTINY-Breast04 and DESTINY-Breast06 trials ...

Emrelis is the first FDA-approved treatment for previously treated patients with locally advanced or metastatic non-squamous non-small cell lung cancer with high c-Met protein overexpression.